Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PELLETIER v. ENDO INTERNATIONAL PLC et al
Case Number:
2:17-cv-05114
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
- Bleichmar Fonti
- Elliott Greenleaf
- Goldman Scarlato
- Hangley Aronchick
- Kaskela Law
- Labaton Keller
- Latham & Watkins
- Morgan Lewis
- Pomerantz LLP
- Pribanic & Pribanic
- Robbins Geller
- Saxton & Stump
Companies
Sectors & Industries:
-
September 18, 2019
Pa. Judge Questions 'Economics' Of Endo Antitrust Claims
A Pennsylvania federal judge voiced doubt on Wednesday that antitrust claims by Endo Pharmaceuticals shareholders were suitable for a jury, saying the allegations of parallel price increases among the company and its competitors are contrary to economics.
-
October 29, 2018
Endo Shareholders Fight Bid To Nix Generic Price-Fixing Suit
A proposed class of Endo Pharmaceuticals shareholders has asked a Pennsylvania federal judge to reject the company's bid to dismiss a suit claiming the drugmaker inflated stock prices by concealing a conspiracy to fix the prices of generic drugs.
-
June 20, 2018
Bleichmar Fonti To Lead Endo Investors' Par Pharma Suit
A Pennsylvania federal judge appointed Bleichmar Fonti & Auld LLP as lead counsel in Endo International PLC shareholders' suit claiming the company concealed knowledge of alleged price-fixing by Par Pharmaceutical Holdings Inc. before acquiring the business, finding Tuesday that the firm's client was best suited to lead the proposed class action.
-
November 15, 2017
Endo Concealed Unit's Alleged Price-Fixing, Investors Say
Endo International PLC shareholders hit the drugmaker with a proposed class action Tuesday in Pennsylvania federal court claiming it didn't properly disclose that Par Pharmaceutical Holdings Inc., which the company acquired in 2015, has allegedly colluded to fix generic-drug prices.
- ← Previous
- 1
- 2
- Next →